Search filters

List of works by Bob W van Oosten

A phase II trial of anti-CD4 antibodies in the treatment of multiple sclerosis.

scientific article published in July 1996

Anti-natalizumab antibodies during 8 years of natalizumab treatment: effect on natalizumab concentration and α4-integrin receptor saturation

scientific article published on 19 April 2019

Application of serum natalizumab levels during plasma exchange in MS patients with progressive multifocal leukoencephalopathy

scientific article published on 30 July 2014

Author response

scientific article published on 01 July 2013

Brain miliary enhancement

scientific article published on 10 January 2020

CLIPPERS and its mimics: evaluation of new criteria for the diagnosis of CLIPPERS

scientific article published on 09 May 2019

Challenges in multi-plex and mono-plex platforms for the discovery of inflammatory profiles in neurodegenerative diseases

scientific article published on 24 March 2012

Choosing drug therapy for multiple sclerosis. An update.

scientific article

Diffuse alveolar hemorrhage as an early complication of alemtuzumab treatment: A case report of a multiple sclerosis patient and an overview of 14 cases

scientific article published on 16 November 2020

Disease activity following pregnancy-related discontinuation of natalizumab in MS.

scientific article published on 5 December 2017

Emerging safety issues in alemtuzumab-treated MS patients

scientific article published on 01 August 2019

Erratum to: Progressive multifocal leukoencephalopathy in patients treated with fumaric acid esters: a review of 19 cases

scientific article published on 01 August 2017

Heterogeneous imaging characteristics of JC virus granule cell neuronopathy (GCN): a case series and review of the literature

scientific article

High work absence around time of diagnosis of multiple sclerosis is associated with fatigue and relapse rate

scientific article published on 16 March 2019

Increased production of tumor necrosis factor alpha, and not of interferon gamma, preceding disease activity in patients with multiple sclerosis.

scientific article published in June 1998

Indolent course of progressive multifocal leukoencephalopathy during natalizumab treatment in MS

scientific article published on 01 February 2011

Interleukin-1 receptor antagonist gene polymorphism and multiple sclerosis

scientific article published on 01 October 1995

Interleukin-2 therapy does not exacerbate multiple sclerosis

scientific article published on 01 August 1997

More on PML in Patients Treated with Dimethyl Fumarate. Author reply

Multiple sclerosis following treatment with a cannabinoid receptor-1 antagonist.

scientific article

Multiple sclerosis therapy. A practical guide.

scientific article published on February 1995

Neuromyelitis optica spectrum disorder mimicking multiple sclerosis.

scientific article published on 29 June 2017

PML in a patient treated with dimethyl fumarate from a compounding pharmacy

scientific article published on 01 April 2013

PML in a patient without severe lymphocytopenia receiving dimethyl fumarate

scientific article published on 01 April 2015

Patients' expectations of autologous hematopoietic stem cell transplantation as a treatment for MS

scientific article published on 24 October 2019

Progressive cognitive disturbances in a 17-year-old boy

scientific article published on January 2015

Progressive multifocal leukoencephalopathy in patients treated with fumaric acid esters: a review of 19 cases

scientific article

Response: Brain miliary enhancement

scientific article published on 25 March 2020

Serum neurofilaments as candidate biomarkers of natalizumab associated progressive multifocal leukoencephalopathy

scientific article published on 26 June 2019

TNF-alpha promoter polymorphisms, production and susceptibility to multiple sclerosis in different groups of patients

scientific article published on 01 February 1997

Time is vision in recurrent optic neuritis

scientific article

Treatment of multiple sclerosis with the monoclonal anti-CD4 antibody cM-T412: results of a randomized, double-blind, placebo-controlled, MR-monitored phase II trial

scientific article (publication date: August 1997)

What went wrong? The flawed concept of cerebrospinal venous insufficiency.

scientific article

Whipple's disease in mentally retarded patients: report of two cases

scientific article published on 21 June 2007